| Revenue growth | 34% YoY consolidated revenue growth in Q1 FY27. |
|---|---|
| Margins | EBITDA margins improved to 19.3% from 16.9% YoY (consolidated). |
| Demand visibility | Strong domestic and global demand for battery materials and specialty chemicals. |
Growth
Consolidated revenue rose 34% to INR 250.3 crore; EBITDA up 53% to INR 48.2 crore; PAT surged 67% to INR 17.1 crore.
Outlook
Projecting significant expansion in battery chemicals; total estimated project cost for Neogen Ionics (Dahej/Pakhajan) at INR 1,795 crore.
Risks
Higher finance costs (up 64% YoY) due to debt for CAPEX; geopolitical supply chain inflation; temporary Dahej plant shutdown costs.
Last quarter's promises, checked
Delivered
- Guided Q4FY26 revenue growth → delivered 22% YoY growth (= BEAT)
- Guided EBITDA margin stability → delivered 17.8% (= BEAT)
- Guided standalone revenue INR 875-950cr for FY27 → reaffirmed in current call (= BEAT)
Partly delivered
- Guided Dahej commissioning Q1FY27 → delayed to June 2026 due to labor shortages (= PARTIAL)
Investor Presentation filed with BSE, NSE: NEOGEN. Summary written with AI assistance from the document.
Neogen Chemicals Ltd: key numbers
- Share price
- ₹2,385.20
- Market cap
- ₹7,166 Cr
- Revenue (annual)
- ₹862.0 Cr
- Net profit (annual)
- ₹28.75 Cr
- P/E (TTM)
- 201.5×Sector 37.5×
- Promoter holding
- 48.31%-2.92% QoQ
- FII holding
- 4.51%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Neogen Chemicals Ltd
All →Neogen Chemicals Capital Structure Change
Neogen Chemicals' subsidiary, Neogen Morita New Materials Limited, approved a preferential issue of 7,20,000 equity shares worth ₹76.80 Crore to Morita Investment Limited.
- Value
- ₹76.80 Cr
Neogen Chemicals Credit Rating
CRISIL Ratings reaffirmed and revised outlooks for Neogen Chemicals and subsidiary Neogen Ionics' facilities and debt, citing improved financial risk profile and completed QIP funding.
Neogen Chemicals Debt & Borrowing: ₹1.63 Cr
Neogen Chemicals has paid the interest on its listed non-convertible debentures for September 2026, totaling ₹1.63 Crore.
- Value
- ₹1.63 Cr
Neogen Chemicals Other Announcement
Neogen Chemicals Ltd has submitted its quarterly shareholding pattern disclosure as per SEBI regulations. This routine filing details the current equity distribution among promoters and public shareholders.
Neogen Chemicals Capital Structure Change
Neogen Chemicals Limited allotted equity shares via a Qualified Institutional Placement (QIP). The allotment increases the total paid-up share capital of the company.
Neogen Chemicals Fund Raise of ₹600 Cr
Neogen Chemicals is raising funds via a Qualified Institutional Placement of 26.61 lakh equity shares. This issuance is valued at approximately ₹600 Crore.
- Value
- ₹600.0 Cr